The National Association for Biomedical Research (NABR) provides a unified voice in Washington for the scientific community on legislative and regulatory matters affecting animal research. NABR works to safeguard the future of biomedical research on behalf of its more than 360 public and private universities, medical and veterinary schools, teaching hospitals, health advocacy organizations, professional societies, pharmaceutical and biotechnology industries, and other animal research-related institutions and companies.
TAKE ADVANTAGE OF ALL THE
BENEFITS OF MEMBERSHIP
Individuals at NABR member institutions are provided with full access to the NABR Members Only section of our website. The Members Only section contains several resources including recordings of NABR webinars, archives of the NABR Update, FOIA and state open records law resources, tools and tips for communicating with Congress, a state laws database and a member resource center containing a broad array of useful fact-sheets, publications and research tools.
Your Voice in Washington
NABR advocates on behalf of its members at all levels of the federal government: Congress, USDA, NIH, FDA, CDC and the executive branch. NABR communicates the essential role of animals in research by encouraging supportive legislation, providing comments on pending proposals, presenting testimony at congressional hearings, and serving as an information source for congressional staff and constituents.
Crisis Management Support
Drawing on more than 35 years of experience, NABR provides unparalleled crisis management support. NABR supports its members and subscribers with planning advice, coordination and emergency support in times of crisis.
Webinars and Training
With membership, your institution will receive unlimited complimentary access to our quarterly webinars along with a host of other services and educational opportunities.
MEMBERSHIP INFORMATION FORM
*are required for all membership requests.
If you ARE AT A NABR MEMBER ORGANIZATION AND would like to receive NABR EMAILS, PLEASE SPECIFIY IN THE COMMENT SECTION.